25 April 2019 1 Min Read
Pharma firms Astellas and Amgen to pay $125m after probe in co-payment scheme
The two allegedly used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of their medications
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In